ROIV
#492
Roivant Sciences Ltd. - Common Shares
37.5 8 USD
+0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.26%
Variación mensual
+10.89%
Variación en los últimos 6 meses
+30.80%
Cambio anual
+105.24%
Cierres anteriores
36.7 5
Open
37.5 8
Mínimo
37.5 8
Máximo
37.5 8
Volumen
179
Financials
- Market Capitalization 27.14 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-51.3
Relación precio/flujo de caja
2 326.88
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 444 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.56 USD | -1.02% | +3.36% | -17.82% | -47.73% | 31.65 B USD | ||
| 485 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.92 USD | +0.19% | +2.30% | +3.36% | +66.18% | 27.65 B USD | ||
| 497 |  BNTX BioNTech SE - American Depositary Shares | 111.40 USD | -1.03% | +0.43% | +20.56% | +9.51% | 26.73 B USD | ||
| 501 |  INSM Insmed Incorporated - Common Stock | 121.39 USD | -2.41% | -2.91% | +16.74% | -25.09% | 26.51 B USD |